| Identification | Back Directory | [Name]
MTH1-IN-2 | [CAS]
901044-91-5 | [Synonyms]
MTH1-IN-2
MTH1IN2,MTH-1-IN-2,MTH1 IN 2
3-Quinolinecarboxamide, 1,4-dihydro-6-[[(3-methoxyphenyl)amino]sulfonyl]-N-(2-methylcyclohexyl)-4-oxo- | [Molecular Formula]
C24H27N3O5S | [MDL Number]
MFCD14754997 | [MOL File]
901044-91-5.mol | [Molecular Weight]
469.55 |
| Hazard Information | Back Directory | [Uses]
MTH1-IN-2 is a MutT homolog 1 (MTH1) inhibitor extracted from patent WO2016135138A1, Compound (6), MTH1-IN-2 can be used for the research of cancer. Anti-tumor activity[1]. | [References]
[1] Kilian Huber. Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer. WO2016135138A1. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
|